Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 389 followers
Latest posts
Last updated about 1 hour ago
Global pharma manufacturing output surged in '25 in 'front-loading' response to US tariff threats: report
about 1 hour ago
While the threat of U.S. import tariffs prompted a surge in drug...
Biosimilar execs optimistic on the state of US biosims as Sandoz locks in on ‘golden decade’ to come
about 4 hours ago
Executives from top U.S. biosimilar makers are optimistic about the future of...
Invivyd teams up with Olympic skier Lindsey Vonn for antibody education
about 6 hours ago
As Lindsey Vonn’s comeback run heads toward a peak with Team USA...
CEPI bankrolls $30M Ebola vaccine collaboration with Merck, SK Biosciences and others
about 6 hours ago
The project, which involves Merck, SK Biosciences, Hilleman Laboratories and CDMO IDT...
Lundbeck ‘not willing to compromise’ on M&A strategy after missed Avadel attempt: exec
about 6 hours ago
Despite falling short in its recent bid to snatch Avadel from Alkermes...
Trump's Davos drug pricing claims decried as 'fake news' by French presidency
about 6 hours ago
After U.S. President Donald Trump took the stage at the World Economic...
Samsung Bio sticks landing on 2025 as it becomes first Korean biopharma to hit 2T won profit threshold
about 9 hours ago
CDMO Samsung Biologics grew sales more than 30% last year to around...
In J&J talc litigation, N.J. court-appointed official recommends allowing expert testimony
1 day ago
In Johnson & Johnson's long-running talc litigation, a court-appointed special master has...
Led by Darzalex surge, J&J expects revenue to reach $100B in 2026
1 day ago
Led by cancer standout Darzalex, Johnson & Johnson projects that its 2026...
IntraBio's Aqneursa, on a roll with EU approval, races toward another rare disease indication with phase 3 win
1 day ago
The company announced a phase 3 win in the rare neurodegenerative disease...
Pfizer CEO lays blame for US vaccine woes on RFK Jr.'s 'anti-science' stance: WSJ
1 day ago
While much of the biopharma industry has spent the past 12 months...
Curia's Mass. plant closure to eliminate 81 jobs
1 day ago
Curia Global is laying off 81 employees as part of its plan...